XML 30 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited condensed consolidated interim statement of comprehensive income - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses        
Research and development $ (8,397) $ (7,088) $ (26,810) $ (21,570)
General and administration (4,224) (2,631) (10,558) (8,493)
Loss from operations (12,621) (9,719) (37,368) (30,063)
Finance income 2,535 2,438 7,760 6,049
Finance expense (181) (184) (538) (534)
Movement of expected credit loss (2) (17) 45 1
Foreign exchange (loss)/gain (1,845) 1,833 (58) 232
Total other income 507 4,070 7,209 5,748
Loss before tax (12,114) (5,649) (30,159) (24,315)
Tax charge/(credit) 0 0 0 0
Loss for the period (12,114) (5,649) (30,159) (24,315)
Items that may be reclassified to profit or loss        
Fair value movement on marketable securities 908 (428) 258 (1,216)
Currency translation adjustment 1,622 (1,780) (113) (161)
Total comprehensive loss for the period (9,584) (7,857) (30,014) (25,692)
Attributable to owners:        
Loss for the period (12,114) (5,649) (30,159) (24,315)
Total comprehensive loss for the period $ (9,584) $ (7,857) $ (30,014) $ (25,692)
Loss per share        
Basic loss per share (in dollars per share) $ (0.23) $ (0.11) $ (0.58) $ (0.47)
Diluted loss per share (in dollars per share) $ (0.23) $ (0.11) $ (0.58) $ (0.47)